Sort by:

select Language:



Mhgap Humanitarian Intervention Guide (mhGAP-HIG): Clinical management of mental, neurological and substance use conditions in humanitarian emergencies

World Health Organization, UN High Commissioner for Refugees, (2015)


The new guide provides practical, first-line management recommendations for mental, neurological and substance use conditions. Contents include modules on assessing and managing conditions such as acute stress, grief, moderate-severe depressive disorder, post-traumatic stress disorder, epilepsy, and harmful use of alcohol and drugs.
http://apps.who.int/iris/bitstream/10665/162960/1/...


Guía de intervención mhGAP para los trastornos mentales, neurológicos y por consumo de sustancias en el nivel de atención de salud no especializada Versión 2.0

World Health Organization WHO, Eds.: PAHO, (2017)


Las directrices actualizadas del mhGAP, la retroalimentación de información y la evaluación de la versión 1.0 de la GI-mhGAP por los usuarios han permitido la revisión y elaboración de esta versión actualizada de la guía. En el año 2015, se llevó a cabo y se publicó una actualización completa de las directrices mhGAP conforme a la metodología de la OMS para la formulación de directrices, que incluyó el proceso de análisis de datos científicos y la síntesis y formulación de recomendaciones mediante la participación de un grupo de expertos internacionales e instituciones con experiencia apropiada: médicos clínicos, investigadores, directores de programa, formuladores de políticas y usuarios de los servicios. Se pueden encontrar detalles de los métodos y las recomendaciones actualizadas en el centro de datos de investigación del mhGAP: http://www.who.int/ mental_health/mhgap/evidence/es/.
http://iris.paho.org/xmlui/handle/123456789/34071


mhGAP Intervention Guide Mental Health Gap Action Programme Version 2.0 for mental, neurological and substance use disorders in non-specialized health settings

Tarun Dua, Nicolas Clark, Neerja Chowdhary et al., Eds.: World Health Organisation (WHO), (2016)


The key updates include: content update in various sections based on new evidence; design changes for enhanced usability; a streamlined and simplified clinical assessment that includes an algorithm for follow-up; inclusion of two new modules - Essential Care and Practice that includes general guidelines and Iminterventions and implementation module to support the proposed interventions by necessary infrastructure and resources; and, revised modules for Psychoses, Child and Adolescent Mental and Behavioural Disorders and Disorders due to Substance Use
http://apps.who.int/iris/bitstream/10665/250239/1/...


Antidepressant medication in comparison with psychological treatment for moderate to severe depressive disorder

World Health Organization, Eds.: WHO, (2015)


Q7. SCOPING QUESTION: In adults with moderate-severe depressive disorder, what is the effectiveness and safety of antidepressant medication (ADM) in comparison with psychological treatment?
https://www.who.int/mental_health/mhgap/evidence/d...


Depression: slides (mhGAP)

World Health Organization, Eds.: WHO, (2015)


Session outline •Introduction to depression •Assessment of depression •Management of depression •Follow-up •Review
https://www.who.int/mental_health/mhgap/training_m...


Dementia mhGAP Training of Health-care Providers. Training manual and supporting material

World Health Organization, Eds.: WHO, (2015)


DEM supporting material • Person stories • Role plays • Case scenarios • Treatment planning handouts • Treatment planning suggestions • Multiple choice questions • Video link Activity 3: mhGAP DEM module – assessment
https://www.who.int/mental_health/mhgap/training_m...


Strategies aimed at improving community attitudes

World Health Organization, Eds.: WHO, (2012)


Q13: Are strategies aimed at improving community attitudes towards mental, neurological and substance use conditions (e.g. anti-stigma campaigns) feasible and effective?
https://www.who.int/mental_health/mhgap/evidence/p...


Second-generation antipsychotic medications for psychotic disorders (including schizophrenia)

World Health Organization, Eds.: WHO, (2012)


Q14. SCOPING QUESTION: In adults with psychotic disorders (including schizophrenia), what is the comparative effectiveness and safety of second-generation antipsychotic medications?
https://www.who.int/mental_health/mhgap/evidence/p...


99 hits